@article{aaab9af282b44aa3867245d3eaf01a4d,
title = "ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective",
abstract = "There has been no major change of practice in gastrointestinal oncology at the European Society for Medical Oncology (ESMO) symposium 2021, but confirmation that immunotherapy in combination with chemotherapy has become standard of care in several indications. The European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Track Cancer Group has selected important phase II and III trials presented during the symposium across all gastrointestinal cancers as well as early reports on new drugs or new combinations that may change practice in the future.",
keywords = "colorectal cancer, neuroendocrine tumours, oesophagus cancer, pancreatic cancer, stomach cancer",
author = "T. Koessler and M. Alsina and D. Arnold and I. Ben-Aharon and M. Collienne and Lutz, {M. P.} and C. Neuzillet and R. Obermannova and M. Peeters and F. Sclafani and E. Smyth and Valle, {J. W.} and Wagner, {A. D.} and L. Wyrwicz and E. Fontana and M. Moehler",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
month = apr,
doi = "10.1016/j.esmoop.2022.100392",
language = "אנגלית",
volume = "7",
journal = "ESMO Open",
issn = "2059-7029",
publisher = "Elsevier B.V.",
number = "2",
}
